Danielle Woods
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.
Journal: The Lancet. Infectious diseases
Published: October 09, 2023
ChAdOx1 nCoV-19 vaccination generates spike-specific CD8+ T cells in aged mice.
Journal: Immunology and cell biology
Published: February 20, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Journal: Clinical and experimental immunology
Published: November 01, 2022
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.
Journal: Cell reports. Medicine
Published: July 04, 2022
Using consensus methods to prioritize modifiable risk factors for development of manifestations of frailty in hospitalized older adults.
Journal: Nursing open
Published: May 23, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 18, 2022
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.
Journal: EBioMedicine
Published: May 03, 2022
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Journal: Lancet (London, England)
Published: June 24, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026